-
1
-
-
0030931159
-
Therapy of re-treatment with alpha interferon
-
Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo G. Therapy of re-treatment with alpha interferon. Hepatology 1997: 26: 137S-142S.
-
(1997)
Hepatology
, vol.26
-
-
Alberti, A.1
Chemello, L.2
Noventa, F.3
Cavalletto, L.4
De Salvo, G.5
-
2
-
-
0026772470
-
Long term follow-up of patients with chronic hepatitis C treated with alpha interferon
-
Shindo M, DiBisceglie AM, Hoofnagle JH, Long term follow-up of patients with chronic hepatitis C treated with alpha interferon. Hepatology 1992: 15: 1013-1016.
-
(1992)
Hepatology
, vol.15
, pp. 1013-1016
-
-
Shindo, M.1
Dibisceglie, A.M.2
Hoofnagle, J.H.3
-
3
-
-
0027466712
-
Serum HCV-RNA Levels in patients with chronic hepatitis C given a second course of interferon alpha treatment after relapse following initial treatment
-
Weiland Ö, Zhang Y-Y, Widell A. Serum HCV-RNA Levels in patients with chronic hepatitis C given a second course of interferon alpha treatment after relapse following initial treatment. Scand J Infect Dis 1993: 25: 25-30.
-
(1993)
Scand J Infect Dis
, vol.25
, pp. 25-30
-
-
Weiland, Ö.1
Zhang, Y.-Y.2
Widell, A.3
-
4
-
-
0028043706
-
Retreatment of chronic hepatitis C with interferon
-
Toyoda H, Nakano S, Takeda Y, Rumada T, Sugiyama K, Osada T et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994: 89: 1453-1457.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 1453-1457
-
-
Toyoda, H.1
Nakano, S.2
Takeda, Y.3
Rumada, T.4
Sugiyama, K.5
Osada, T.6
-
5
-
-
17344367586
-
Re-treatment with interferon alpha of patients with chronic hepatitis C
-
Chow V, Boyer N, Ponteau M et al: Re-treatment with interferon alpha of patients with chronic hepatitis C. Hepatology 1998: 27: 1144-1148.
-
(1998)
Hepatology
, vol.27
, pp. 1144-1148
-
-
Boyer, N.1
Ponteau, M.2
-
6
-
-
17344364796
-
Better efficacy of a 12 month interferon alpha 2b retreatment in patients with chronic hepatitis C relapsing after a 6 month treatment: A multicenter, controlled, randomized trial
-
Payen JL, Izopet V, Galindo-Migeot V et al. Better efficacy of a 12 month interferon alpha 2b retreatment in patients with chronic hepatitis C relapsing after a 6 month treatment: A multicenter, controlled, randomized trial. Hepatology 1998: 28: 16801686.
-
(1998)
Hepatology
, vol.28
, pp. 16801686
-
-
Payen, J.L.1
Izopet, V.2
Galindo-Migeot, V.3
-
7
-
-
0009636604
-
Two year Interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C
-
Picciotto A, Brizzol R, Campo N et al. Two year Interferon retreatment may induce a sustained response in relapsing patients with chronic hepatitis C. Hepatology 1996: 24: 273A.
-
(1996)
Hepatology
, vol.24
-
-
Picciotto, A.1
Brizzol, R.2
Campo, N.3
-
8
-
-
0031945834
-
Retreatment of chronic hepatitis C with Consensus interferon
-
Heathcote J, Keef EB, Lee SS. Retreatment of chronic hepatitis C with Consensus interferon. Hepatology 1998: 27: 1136-1143.
-
(1998)
Hepatology
, vol.27
, pp. 1136-1143
-
-
Heathcote, J.1
Keef, E.B.2
Lee, S.S.3
-
9
-
-
0032547944
-
Recombinat interferon alpha-2b alone or in combination with ribavirin for retreatment of interferon relapse in chronic hepatitis C
-
Davis G-L, Esteban R, Rustgi V et al. Recombinat interferon alpha-2b alone or in combination with ribavirin for retreatment of interferon relapse in chronic hepatitis C. N Engl J Med 1998: 339: 1493-1499.
-
(1998)
N Engl J Med
, vol.339
, pp. 1493-1499
-
-
Davis, G.-L.1
Esteban, R.2
Rustgi, V.3
-
10
-
-
0032585237
-
Randomised trial of Interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C
-
Poynard T, Marcellin P, Lee SS et al. Randomised trial of Interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. Lancet 1998: 352: 14261432.
-
(1998)
Lancet
, vol.352
, pp. 14261432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.S.3
-
11
-
-
0032547938
-
Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
-
McHutchison JG, Gordon SC, Schiff ER et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N EngI J Med 1998: 339: 14851492.
-
(1998)
N EngI J Med
, vol.339
, pp. 14851492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
|